Who Owns Cue Biopharma Stock?
NASDAQ: CUEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 33.90%
- Held by insiders
- 16.57%
- Institutional holders
- 66
- Institutions 33.9%
- Insiders 16.6%
- Public and other 49.5%
Who owns Cue Biopharma stock?
Institutional investors own about 33.9% of Cue Biopharma's shares, spread across 66 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 16.57% of CUE.
The largest institutional holders are Bleichroeder LP (5.04%), Vanguard Capital Management LLC (4.27%) and Driehaus Capital Management, LLC (4.02%). Together, the top 10 institutions control 26.5% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their CUE positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CUE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Bleichroeder LP | 366.15K | 5.04% | -1.2% |
| Vanguard Capital Management LLC | 309.95K | 4.27% | +91.7% |
| Driehaus Capital Management, LLC | 292.14K | 4.02% | +100.0% |
| Vivo Capital, LLC | 280.06K | 3.86% | +100.0% |
| Morgan Stanley | 203.96K | 2.81% | +30160.7% |
| UBS Group AG | 111.50K | 1.53% | +317.6% |
| Ikarian Capital, LLC | 104.36K | 1.44% | +100.0% |
| Nantahala Capital Management, LLC | 96.05K | 1.32% | +100.0% |
| Tetragon Partners GP Ltd. | 93.82K | 1.29% | +100.0% |
| Geode Capital Management, LLC | 68.91K | 0.95% | +44.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CUE
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 111.87K | 1.54% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 47.09K | 0.65% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 31.09K | 0.43% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 11.90K | 0.16% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 10.47K | 0.14% |
| iShares Trust-iShares Micro-Cap ETF | 8.70K | 0.12% |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 1.81K | 0.02% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 1.72K | 0.02% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 1.02K | 0.01% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 747 | 0.01% |
Frequently asked questions
Who is the largest shareholder of Cue Biopharma?
Bleichroeder LP is the largest institutional shareholder of CUE, owning 5.04% of shares outstanding (366.15K shares) as of its latest 13F filing.
What percentage of Cue Biopharma is owned by institutions?
Institutions own about 33.9% of CUE shares and 40.6% of the public float.
How much of Cue Biopharma do insiders own?
Insiders, such as officers and directors, own about 16.57% of CUE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.